NeutralLOW severityHealthcare & Pharma63d ago

Johnson says no moratorium on AI, would give China competitive edge

Image: Investing.com

At a glance

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about JNJ. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · Johnson & JohnsonEvent risk Low

Nothing reported about Johnson & Johnson across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 26% a year
Now $278.70Week $268.40–$289.00 (±3.7%)Month $257.59–$299.81 (±7.6%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: In healthcare, the calendar is the catalyst: trial readouts, FDA dates and pricing rules drive most of the moves.
  • How the stock is trading: $JNJ -1.89% in the latest session.
  • Timing: It was published while New York was trading, so the day's move may already include the first reaction.

Where the stock stands

Johnson & Johnson ($JNJ) declined 1.89% to $277.20 in the latest session. Over the past month it is up 9.8%. It now sits 4.5% under the 52-week high of $290.25 and 40% above the year's low of $198.53. The high sits 46% above the low, a moderate range for a year.

How much coverage it is getting

This story is more than a month old. Since then Wook has filed 11 newer stories on Johnson & Johnson in the last 30 days, 0 of them this week. By their wording, 18% read bullish, 55% neutral and 27% bearish.

The bigger picture

In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.

Coming up

$JNJ earnings in 70 days, a date set before this story ran.

What to watch next

The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $JNJ page, and they say what management has disclosed without a reporter in between. Where several outlets agree is usually the news; where they differ is the angle. Wook AI, at the top of the page, can work out how far $JNJ is from its high or compare this week's coverage with earlier weeks.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Investing.com published this on September 15, 2026. $JNJ has moved +3.71% ($267.28 to $277.20). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy